SARS-CoV-2 and Influenza Coinfection Among Persons Tested in US Pharmacies
This cohort study describes the prevalence of SARS-CoV-2 and influenza coinfection, associated risk factors, and treatment among individuals diagnosed in US pharmacies.
Authors
- Jessica Sprinkles (ORCID: https://orcid.org/0009-0003-5731-7324)
- Pragna Patel (ORCID: https://orcid.org/0000-0003-1386-8194)
- Timothy M. Uyeki (ORCID: https://orcid.org/0000-0001-5338-8668)
- Henry T. Walke (ORCID: https://orcid.org/0000-0001-6550-5462)
- Andrew Godoshian (ORCID: https://orcid.org/0009-0005-6203-6521)
- Marcus Siddall (ORCID: https://orcid.org/0000-0002-3977-7517)
- Joseph Miller
Institutions
- University of North Carolina at Chapel Hill (US)
- Centers for Disease Control and Prevention (US)
- National Center for Immunization and Respiratory Diseases (US)
- Office of Readiness and Response (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.44758
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00